Browsing: All news

Company’s ‘Immune Refresh’ approach expand

Oxford University analysis finds semaglutide doe

RF Longevity Founder Gary Arendash talks immunit

Company aims to extend female fertility window w

New insights into transcription factors and chro

If approved, HMTM would become the first oral Al

Recent study reveals significant deviations in t

Alamar Bio joins forces with Biomarkers of Aging

Significant Series B funding will enable clinica

Altos Co-founder and Chief Scientist Rick Klauns